52 / 58
A phase I study of an agonist CD40 monoclonal antibody
(CP-870,893) in combination with gemcitabine in patients with
advanced pancreatic ductal adenocarcinoma
Beatty et al, Clin Cancer Res 2013
Additional trials with CD40 agonist in monotherapy or combinations
with gem-based QTA are ongoing (NCT02588443, NCT02829099)
N 28
RR 19%